NOV 21, 2018 9:00 AM PST

Current Controversies in the Epidemiology, Diagnosis, and Management of Vaginal Infections

Sponsored by: Roche Molecular Diagnostics
C.E. Credits: P.A.C.E. CE RACE
Speaker
  • Associate Professor of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham
    Biography
      Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. Her clinical and research interests focus on HIV and sexually transmitted diseases (specifically vaginal infections) among sexual minority women of color and women with increased numbers of recent sexual partners. Dr. Muzny currently has a K23 career development award from the National Institute of Allergy and Infectious Diseases to study the pathogenesis of bacterial vaginosis among African American women who have sex with women. She is currently an Associate Professor in the Division of Infectious Diseases at UAB, a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center, and an Associate Scientist for the UAB Center for AIDS Research.

    Abstract
    DATE: November 21,2018
    TIME:  09:00am PST, 12:00pm EST
     
    Vaginal infections are a source of considerable morbidity among women. It is estimated that there are more than 10 million office visits per year due to vaginal infections. The three main causes of infectious vaginitis are vulvovaginal candidiasis (VVC), trichomoniasis, and bacterial vaginosis (BV). Each one may cause distressing vaginal symptomatology and the latter two may cause upper genital tract complications. These infections may also contribute to the transmission and acquisition of HIV. This webinar reviews current controversies in the epidemiology, diagnosis, and management of vaginal infections, particularly BV and trichomoniasis. It will include a discussion as to whether or not BV is a sexually transmitted infection, the pathogenesis of incident BV and the role of the BV biofilm, and updated BV treatment recommendations. With regards to trichomonas, the webinar will discuss whether or not it should be a reportable disease, new diagnostic methods, and updated treatment recommendations.
     
    At the end of the webinar, learners should be able to:
    • Describe the epidemiology of BV, particularly as it relates to sexual transmission
    • Be knowledgeable on updated treatment options for BV and trichomonas
    • Be knowledgeable on currently available trichomonas nucleic acid amplification tests

    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 02, 2020 9:00 AM PDT
    C.E. CREDITS
    JUN 02, 2020 9:00 AM PDT
    DATE: June 2, 2020 TIME: 9:00am PT, 12:00pm ET Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the m...
    Loading Comments...
    Show Resources
    Attendees
    • See more